Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases

OBJECTIVE: The European Association of Urology (EAU) recommends a bone scan for newly diagnosed unfavorable intermediate- and high-risk prostate cancer. We aimed to validate the screening criteria for bone metastases in patients with treatment-naïve prostate cancer. METHODS: This single-center retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rud, Erik, Noor, Daniyal, Galtung, Kristina Flor, Ottosson, Fredrik, Jacewicz, Maciej, Baco, Eduard, Lauritzen, Peter Mæhre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Urogenital
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705459/
https://www.ncbi.nlm.nih.gov/pubmed/35939081
http://dx.doi.org/10.1007/s00330-022-08945-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705459/
https://www.ncbi.nlm.nih.gov/pubmed/35939081
http://dx.doi.org/10.1007/s00330-022-08945-7

Ejemplares similares